These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Primrose JN; Johnston D Br J Surg; 1989 Feb; 76(2):140-4. PubMed ID: 2702445 [TBL] [Abstract][Full Text] [Related]
10. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592 [TBL] [Abstract][Full Text] [Related]
11. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Gray JL; Debas HT; Mulvihill SJ Arch Surg; 1991 Oct; 126(10):1231-5; discussion 1235-6. PubMed ID: 1929823 [TBL] [Abstract][Full Text] [Related]
12. Long acting somatostatin analogue in dumping syndrome. Tulassay Z; Tulassay T; Gupta R; Cierny G Br J Surg; 1989 Dec; 76(12):1294-5. PubMed ID: 2691013 [TBL] [Abstract][Full Text] [Related]
13. The place of octreotide in the medical management of the dumping syndrome. Scarpignato C Digestion; 1996; 57 Suppl 1():114-8. PubMed ID: 8813487 [TBL] [Abstract][Full Text] [Related]
14. [Could delayed action flanreotide be used as substitute for octreotide in the treatment of dumping syndrome?]. Bouché O; Salmon-Ettersperger L; Frémond L; Thiéfin G; Zeitoun P Gastroenterol Clin Biol; 1997; 21(1):84-5. PubMed ID: 9091398 [No Abstract] [Full Text] [Related]
15. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome. Penning C; Vecht J; Masclee AA Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971 [TBL] [Abstract][Full Text] [Related]
16. Octreotide in dumping and short bowel syndromes. Farthing MJ Digestion; 1993; 54 Suppl 1():47-52. PubMed ID: 8359568 [TBL] [Abstract][Full Text] [Related]
17. [(Influence of somatostatin (SS-14) on early dumping reaction in patients after partial gastrectomy) ]. Mörz R; Prager J; Pointner H Z Gastroenterol; 1982 Jun; 20(6):299-304. PubMed ID: 6126965 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials. Li-Ling J; Irving M Postgrad Med J; 2001 Jul; 77(909):441-2. PubMed ID: 11423592 [No Abstract] [Full Text] [Related]
19. Octreotide therapy in dumping syndrome: Analysis of long-term results. Didden P; Penning C; Masclee AA Aliment Pharmacol Ther; 2006 Nov; 24(9):1367-75. PubMed ID: 17059518 [TBL] [Abstract][Full Text] [Related]
20. Long-acting analogue of somatostatin--SMS 201-995--is highly effective in the prevention of clinical symptoms related to the dumping syndrome. Tulassay Z; Tulassay T; Gupta R; Cierny G Ann Surg; 1989 Aug; 210(2):250-2. PubMed ID: 2757427 [No Abstract] [Full Text] [Related] [Next] [New Search]